1. Trends in antimicrobial drug resistance in Salmonella enterica serotypes Typhi and Paratyphi A isolated in Europe, 1999–2001
- Author
-
Threlfall, E.J., Fisher, I.S.T., Berghold, C., Gerner-Smidt, P., Tschäpe, H., Cormican, M., Luzzi, I., Schnieder, F., Wannet, W., Machado, J., and Edwards, G.
- Subjects
- *
SALMONELLA , *MICROBIAL sensitivity tests , *DRUG resistance in microorganisms - Abstract
Results of antimicrobial sensitivity tests for strains of Salmonella enterica serotypes Typhi and Paratyphi A isolated from patients in ten European countries between 1999 and 2001 have been transferred electronically to the Enter-net surveillance hub. For Typhi between 22 and 29% of isolates were multiresistant (to four drugs or more) with decreased susceptibility to ciprofloxacin (MIC 0.25–1.0 mg/l) increasing from 20% in 1999 to 26% in 2001. Nineteen of 169 (11%) strains with decreased ciprofloxacin susceptibility were sensitive to nalidixic acid. For Paratyphi A multiple resistance increased from 9% in 1999 to 25% in 2001 and decreased ciprofloxacin susceptibility from 6 to 17%. Clinicians should be aware of the possibility of treatment failures when fluoroquinolones are used as the first-line drug for infections with Typhi and Paratyphi A, particularly for patients recently returning from areas where drug-resistant strains are endemic. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF